Tonix Pharmaceuticals (TNXP)
(Real Time Quote from BATS)
$0.14 USD
+0.01 (3.78%)
Updated Sep 24, 2024 02:40 PM ET
NA Value
NA Growth NA Momentum NA VGMCompany Summary
Tonix Pharmaceuticals Holding Corp. is a specialty pharmaceutical company focused on developing new pharmaceutical products for CNS conditions. The Company develops therapies for disorders that include fibromyalgia syndrome and post-traumatic stress disorder. Its lead product candidates include TNX-102, for the management of fibromyalgia syndrome and TNX-105 to treat symptoms of post-traumatic stress disorder. Tonix Pharmaceuticals Holding Corp. is headquartered in New York.
Company Summary
General Information
Tonix Pharmaceuticals Holding Corp
26 MAIN STREET SUITE 101
CHATHAM, NJ 07928
Phone: 862-799-9155
Fax: 212-923-5700
Web: http://www.tonixpharma.com
Email: investor.relations@tonixpharma.com
Industry | Medical - Drugs |
Sector | Medical |
Fiscal Year End | December |
Last Reported Quarter | 6/30/2024 |
Exp Earnings Date | 11/14/2024 |
EPS Information
Current Quarter EPS Consensus Estimate | -2.03 |
Current Year EPS Consensus Estimate | -18.00 |
Estimated Long-Term EPS Growth Rate | NA |
Exp Earnings Date | 11/14/2024 |